ES2196150T3 - Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. - Google Patents
Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.Info
- Publication number
- ES2196150T3 ES2196150T3 ES96915808T ES96915808T ES2196150T3 ES 2196150 T3 ES2196150 T3 ES 2196150T3 ES 96915808 T ES96915808 T ES 96915808T ES 96915808 T ES96915808 T ES 96915808T ES 2196150 T3 ES2196150 T3 ES 2196150T3
- Authority
- ES
- Spain
- Prior art keywords
- deployment
- antibodies
- induce
- immunological tolerance
- tolerance induction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001900 immune effect Effects 0.000 title abstract 2
- 230000024664 tolerance induction Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 241000288906 Primates Species 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fats And Perfumes (AREA)
Abstract
LA INVENCION PROPORCIONA UN METODO DE INDUCCION DE TOLERANCIA INMUNOLOGICA Y UN METODO DE PREVENCION DEL RECHAZO DE HETEROINJERTOS. EN AMBOS METODOS, SE ADMINISTRAN COMPOSICIONES DE ANTICUERPO ANTICD4 NO DEPLECIONANTE A UN PRIMATE. TAMBIEN SE PRESENTAN COMPOSICIONES DE ANTICUERPO NO DEPLECIONANTE Y MEDULA OSEA DE DONANTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44373995A | 1995-05-18 | 1995-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2196150T3 true ES2196150T3 (es) | 2003-12-16 |
Family
ID=23762005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96915808T Expired - Lifetime ES2196150T3 (es) | 1995-05-18 | 1996-05-16 | Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP1161955A3 (es) |
JP (1) | JPH11505251A (es) |
AT (1) | ATE238066T1 (es) |
AU (1) | AU715052B2 (es) |
CA (1) | CA2221350A1 (es) |
DE (1) | DE69627665T2 (es) |
DK (1) | DK0840618T3 (es) |
ES (1) | ES2196150T3 (es) |
PT (1) | PT840618E (es) |
WO (1) | WO1996036359A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037454A (en) * | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
WO1998023746A1 (en) * | 1996-11-27 | 1998-06-04 | Genentech, Inc. | Antibody mutants |
US7541443B2 (en) | 2001-06-14 | 2009-06-02 | Tolerrx, Inc. | Anti-CD4 antibodies |
EP1985306A3 (en) * | 2001-06-14 | 2009-04-01 | TolerRx, Inc | CD4-specific antibody TRX1 and uses therefor |
EP1460088A1 (en) | 2003-03-21 | 2004-09-22 | Biotest AG | Humanized anti-CD4 antibody with immunosuppressive properties |
TW200817438A (en) | 2006-08-17 | 2008-04-16 | Hoffmann La Roche | A conjugate of an antibody against CCR5 and an antifusogenic peptide |
CL2008000707A1 (es) | 2007-03-13 | 2008-09-22 | Hoffmann La Roche | Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion. |
US20090022720A1 (en) | 2007-07-20 | 2009-01-22 | Stephan Fischer | Conjugate of an antibody against CD4 and antifusogenic peptides |
EP2262838B1 (en) | 2008-03-13 | 2016-04-13 | Biotest AG | Agent for treating disease |
CN102027018A (zh) | 2008-03-13 | 2011-04-20 | 生物测试股份公司 | 一种治疗疾病的试剂 |
CA2718184A1 (en) | 2008-03-13 | 2009-10-08 | Biotest Ag | Agent for treating disease |
US8637466B2 (en) | 2008-08-11 | 2014-01-28 | Nektar Therapeutics | Multi-arm polymeric alkanoate conjugates |
GB0920944D0 (en) | 2009-11-30 | 2010-01-13 | Biotest Ag | Agents for treating disease |
EP2471543A1 (en) * | 2010-12-02 | 2012-07-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules |
WO2012088422A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
WO2012088445A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
US20140088021A1 (en) | 2011-05-27 | 2014-03-27 | Nektar Therapeutics | Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4904481A (en) * | 1985-04-17 | 1990-02-27 | The Board Of Trustess Of Leland Stanford University | Method of conferring immuno-tolerance to a specific antigen |
GB8608068D0 (en) * | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
GB8912497D0 (en) * | 1989-05-31 | 1989-07-19 | Cobbold Stephen P | Monoclonal antibodies |
GB8928874D0 (en) * | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
GB9020282D0 (en) * | 1990-09-17 | 1990-10-31 | Gorman Scott D | Altered antibodies and their preparation |
-
1996
- 1996-05-16 DK DK96915808T patent/DK0840618T3/da active
- 1996-05-16 DE DE69627665T patent/DE69627665T2/de not_active Expired - Fee Related
- 1996-05-16 AT AT96915808T patent/ATE238066T1/de not_active IP Right Cessation
- 1996-05-16 CA CA002221350A patent/CA2221350A1/en not_active Abandoned
- 1996-05-16 WO PCT/US1996/006912 patent/WO1996036359A1/en active IP Right Grant
- 1996-05-16 EP EP01202886A patent/EP1161955A3/en not_active Withdrawn
- 1996-05-16 EP EP96915808A patent/EP0840618B1/en not_active Expired - Lifetime
- 1996-05-16 JP JP8534995A patent/JPH11505251A/ja not_active Withdrawn
- 1996-05-16 AU AU57479/96A patent/AU715052B2/en not_active Ceased
- 1996-05-16 ES ES96915808T patent/ES2196150T3/es not_active Expired - Lifetime
- 1996-05-16 PT PT96915808T patent/PT840618E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
ATE238066T1 (de) | 2003-05-15 |
AU715052B2 (en) | 2000-01-13 |
DE69627665D1 (de) | 2003-05-28 |
AU5747996A (en) | 1996-11-29 |
WO1996036359A1 (en) | 1996-11-21 |
DK0840618T3 (da) | 2003-08-11 |
JPH11505251A (ja) | 1999-05-18 |
PT840618E (pt) | 2003-08-29 |
CA2221350A1 (en) | 1996-11-21 |
EP0840618B1 (en) | 2003-04-23 |
EP1161955A3 (en) | 2001-12-19 |
EP0840618A1 (en) | 1998-05-13 |
EP1161955A2 (en) | 2001-12-12 |
DE69627665T2 (de) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2196150T3 (es) | Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. | |
AU5055593A (en) | Antibodies specific for HIV | |
PT817847E (pt) | Receptor de il-17 | |
AR001811A1 (es) | Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones | |
ATE233814T1 (de) | Humaner neutralisierender monoklonaler antikörper gegen den die immunschwäche beim menschen hervorringenden virus | |
DE69839587D1 (de) | Enterokokkus antigene und vakzine | |
MY104946A (en) | Antigen antibody conjugate. | |
ES2093778T3 (es) | Nuevos anticuerpos y metodos para su uso. | |
DK0722340T3 (da) | Immunologisk toleranceinducerende middel | |
ATE137802T1 (de) | Monoklonaler antikörper, der mit einer neuen hla- determinante auf mhc-klasse-i-moleküle reagiert, und verfahren zur aktivierung von lymphozyten | |
ATE143376T1 (de) | Gegen die beta-kette des leukozyten-adhäsions- rezeptors gerichtete monoklonale antikörper, verfahren zu ihrer herstellung und ihre verwendung | |
IL221708A0 (en) | Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response | |
BR9809656A (pt) | Composição imunopotencializante | |
ES2110993T3 (es) | Anticuerpos monoclonales especificos para la toxina b de clostridium difficile. | |
EP0866133A3 (en) | A group b streptococcus vaccine | |
GR3029483T3 (en) | Antibodies against t-cells as therapeutics | |
SG48816A1 (en) | Gonococcal anti-idiotypic antibodies and methods and compositions using them | |
CA2015515A1 (en) | Pharmaceutical compositions containing antigen-antibody complexes and uses therefor | |
ATE317269T1 (de) | Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs) | |
MX9300294A (es) | Metodo para inhibir al menos una porcion de una respuesta del anticuerpo especifico del antigeno mediante el sistema inmune de un mamifero | |
TW223019B (es) | ||
ES2051870T3 (es) | Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t. | |
ES2060162T3 (es) | Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina. | |
GB9510753D0 (en) | Method for the molecular cloning of antigens,which are recognised by cd4+lymphocytes | |
DE59704477D1 (de) | Pharmazeutische antigen-/antikörperpräparation |